Format
Items per page
Sort by

Send to:

Choose Destination

Results: 9

Related Articles by Review for PubMed (Select 23099009)

1.

Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: a phase 2 trial.

Robertson KA, Nalepa G, Yang FC, Bowers DC, Ho CY, Hutchins GD, Croop JM, Vik TA, Denne SC, Parada LF, Hingtgen CM, Walsh LE, Yu M, Pradhan KR, Edwards-Brown MK, Cohen MD, Fletcher JW, Travers JB, Staser KW, Lee MW, Sherman MR, Davis CJ, Miller LC, Ingram DA, Clapp DW.

Lancet Oncol. 2012 Dec;13(12):1218-24. doi: 10.1016/S1470-2045(12)70414-X. Epub 2012 Oct 23.

PMID:
23099009
2.

Pathogenesis of plexiform neurofibroma: tumor-stromal/hematopoietic interactions in tumor progression.

Staser K, Yang FC, Clapp DW.

Annu Rev Pathol. 2012;7:469-95. doi: 10.1146/annurev-pathol-011811-132441. Epub 2011 Nov 7. Review.

3.

Plexiform neurofibromas in NF1: toward biologic-based therapy.

Packer RJ, Gutmann DH, Rubenstein A, Viskochil D, Zimmerman RA, Vezina G, Small J, Korf B.

Neurology. 2002 May 28;58(10):1461-70. Review.

PMID:
12041525
4.

Imatinib for the treatment of patients with unresectable and/or metastatic gastrointestinal stromal tumours: systematic review and economic evaluation.

Wilson J, Connock M, Song F, Yao G, Fry-Smith A, Raftery J, Peake D.

Health Technol Assess. 2005 Jul;9(25):1-142. Review.

5.

Spotlight on imatinib mesylate in chronic myeloid leukemia.

Curran MP, Croom KF, Goa KL.

BioDrugs. 2004;18(3):207-10. Review.

PMID:
15161340
6.

Intra-parotid facial nerve multiple plexiform neurofibroma in patient with NF1.

Fadda MT, Verdino G, Mustazza MC, Bartoli D, Iannetti G.

Int J Pediatr Otorhinolaryngol. 2008 May;72(5):553-7. doi: 10.1016/j.ijporl.2008.01.022. Epub 2008 Mar 7. Review.

PMID:
18329107
7.

Diagnostic delay of NF1 in hemifacial hypertrophy due to plexiform neurofibromas.

Overdiek A, Feifel H, Schaper J, Mayatepek E, Rosenbaum T.

Brain Dev. 2006 Jun;28(5):275-80. Epub 2006 Feb 14. Review.

PMID:
16481142
8.

Control of aggressive fibromatosis by treatment with imatinib mesylate. A case report and review of the literature.

Wcislo G, Szarlej-Wcislo K, Szczylik C.

J Cancer Res Clin Oncol. 2007 Aug;133(8):533-8. Epub 2007 Apr 24. Review.

PMID:
17453242
9.

Imatinib mesylate: in the treatment of gastrointestinal stromal tumours.

Croom KF, Perry CM.

Drugs. 2003;63(5):513-22; discussion 523-4. Review.

PMID:
12600228
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk